Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D I Stirling

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|August 16, 1996
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activityG W Muller, L G Corral, M G Shire, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 3, 2001
Safety profile of thalidomide after 53 weeks of oral administration in beagle dogsS K Teo, M G Evans, M J Brockman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Thalidomide analogs and PDE4 inhibitionG W Muller, M G Shire, L M Wong, et al.
Leukemia|January 17, 2003
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivoS Lentzsch, R LeBlanc, K Podar, et al.
Biopharmaceutics & Drug Disposition|October 20, 2000
Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and womenS K Teo, M R Scheffler, K A Kook, et al.
Journal of Clinical Pharmacology|June 14, 2001
Thalidomide dose proportionality assessment following single doses to healthy subjectsS K Teo, M R Scheffler, K A Kook, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha productionG W Muller, R Chen, S Y Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alphaL G Corral, P A Haslett, G W Muller, et al.
Cellular Signalling|June 3, 2014
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunityP H Schafer, A Parton, L Capone, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2001
Thalidomide is distributed into human semen after oral dosingS K Teo, J L Harden, A B Burke, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|August 16, 1996
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activityG W Muller, L G Corral, M G Shire, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 3, 2001
Safety profile of thalidomide after 53 weeks of oral administration in beagle dogsS K Teo, M G Evans, M J Brockman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Thalidomide analogs and PDE4 inhibitionG W Muller, M G Shire, L M Wong, et al.
Leukemia|January 17, 2003
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivoS Lentzsch, R LeBlanc, K Podar, et al.
Biopharmaceutics & Drug Disposition|October 20, 2000
Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and womenS K Teo, M R Scheffler, K A Kook, et al.
Journal of Clinical Pharmacology|June 14, 2001
Thalidomide dose proportionality assessment following single doses to healthy subjectsS K Teo, M R Scheffler, K A Kook, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha productionG W Muller, R Chen, S Y Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alphaL G Corral, P A Haslett, G W Muller, et al.
Cellular Signalling|June 3, 2014
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunityP H Schafer, A Parton, L Capone, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2001
Thalidomide is distributed into human semen after oral dosingS K Teo, J L Harden, A B Burke, et al.
Pageof 3